- Home
- TCRX vs RRGB Comparison
TCRX vs RRGB Comparison
Compare TCRX & RRGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TCRX | RRGB |
|---|---|---|
| Founded | 2018 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.6M | 53.1M |
| IPO Year | 2021 | 2002 |
Fundamental Metrics
Financial Performance| Metric | TCRX | RRGB |
|---|---|---|
| Price | $1.22 | $3.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $7.00 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 1.2M | 341.7K |
| Earning Date | 05-08-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.28 | ★ 73.43 |
| EPS | ★ N/A | N/A |
| Revenue | $10,325,000.00 | ★ $1,315,014,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.81 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 266.65 | N/A |
| 52 Week Low | $0.88 | $2.46 |
| 52 Week High | $2.57 | $7.52 |
Technical Indicators
Market Signals| Indicator | TCRX | RRGB |
|---|---|---|
| Relative Strength Index (RSI) | 56.02 | 59.29 |
| Support Level | $0.93 | $3.84 |
| Resistance Level | $1.21 | $4.42 |
| Average True Range (ATR) | 0.10 | 0.25 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 43.69 | 65.67 |
Price Performance
Historical ComparisonAbout TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. The company's brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. It has one operating and one reportable segment: restaurants.